Could a Common Antidepressant Help Fight COVID-19?
Scientists are researching the potential role a common antidepressant called fluvoxamine could play in preventing severe illness and lung damage in COVID-19 patients.
Source: newsmax.com
Page 16 - Eric Lenze News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Eric Lenze. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Eric Lenze Today - Breaking & Trending Today
Can a common antidepressant help in the COVID-19 fight?
Early last year, Angela Reiersen, a psychiatrist at Washington University in St. Louis, took ill with what she suspected was COVID-19. Because of a shortage of tests at the time, she never found out for sure, and she recovered before long. But the experience got her thinking about something. Reiersen had recently seen research suggesting that an antidepressant called fluvoxamine was useful in treating sepsis, a potentially fatal condition in which the body releases a dangerous imbalance of chemicals known as cytokines into the bloodstream in response to an infection. Might fluvoxamine also be...
Source: latimes.com
Antidepressant plays key role in battling COVID-19 at California horseracing track
Share this article Share this article BERKELEY, Calif., Jan. 15, 2021 /PRNewswire/ -- The COVID-19 Early Treatment Fund (CETF) announced today that the use of the generic antidepressant fluvoxamine helped speed the recovery of dozens of COVID-infected workers at Golden Gate Fields, the Berkeley horse racing venue that reopened Friday. The track physician, Dr. David Seftel, offered fluvoxamine to infected employees after learning about the 100% success rate in avoiding hospitalization in a Phase 2 randomized controlled trial published on November 12, 2020, in the Journal of the American Medica...
Source: prnewswire.com
Podcast: Vaccines have arrived but COVID-19 treatments progressing much more slowly – Washington University School of Medicine in St. Louis
Matt Miller William G. Powderly, MD, discusses COVID-19 cases with staff in the intensive care unit at Barnes-Jewish Hospital. Powderly says that although vaccine development has been rapid, the search for therapies for patients infected with the novel coronavirus has been less successful. A new episode of our podcast, “Show Me the Science,” has been posted. At present, these podcast episodes are highlighting research and patient care on the Washington University Medical Campus as our scientists and clinicians confront the COVID-19 pandemic. COVID-19 vaccine development has been rapid and...
Source: wustl.edu